XIAP and prostate carcinoma: The transcription factor RUNX2 can prevent prostate cancer cell apoptosis [16], and inhibition of X-linked inhibitor of apoptosis (XIAP) is being studied as a strategy to enhance apoptosis and prevent cancer cell proliferation [17].